C1-inactivatorが著効した血管性浮腫の1例 , 多田 紘恵,松山 敏之,工藤 毅,近松 一朗 , 2017, 120, 3, 217-223
Expression of immune-regulatory molecules in circulating tumor cells derived from patients with head and neck squamous cell carcinoma, Chikamatsu, Kazuaki;Tada, Hiroe;Takahashi, Hideyuki;Kuwabara-Yokobori, Yuki;Ishii, Hiroki;Ida, Shota;Shino, Masato, 2019, ORAL ONCOLOGY, 89, 34, 39
Prognostic significance and population dynamics of peripheral monocytes in patients with oropharyngeal squamous cell carcinoma, Takahashi, Hideyuki;Sakakura, Koichi;Tada, Hiroe;Kaira, Kyoichi;Oyama, Tetsunari;Chikamatsu, Kazuaki, 2019, HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 41, 6, 1880, 1888
Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma, Takahashi, Hideyuki;Sakakura, Koichi;Arisaka, Yukiko;Tokue, Azusa;Kaira, Kyoichi;Tada, Hiroe;Higuchi, Tetsuya;Okamoto, Ayako;Tsushima, Yoshito;Chikamatsu, Kazuaki, 2019, ANTICANCER RESEARCH, 39, 6, 3039, 3046
Detection and molecular characterization of circulating tumor cells in advanced head and neck squamous cell carcinoma, Tada, Hiroe;Takahashi, Hideyuki;Ishii, Hiroki;Kuwabara-Yokobori, Yuki;Shino, Masato;Chikamatsu, Kazuaki, 2019, CANCER RESEARCH, 79, 13
Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma, Tada, Hiroe;Takahashi, Hideyuki;Kuwabara-Yokobori, Yuki;Shino, Masato;Chikamatsu, Kazuaki, 2020, ORAL ONCOLOGY, 102
Immunologic characteristics of circulating tumor cells in patients with head and neck squamous cell carcinoma., Tada, Hiroe;Takahashi, Hideyuki;Ishii, Hiroki;Kuwabara-Yokobori, Yuki;Ida, Shota;Shino, Masato;Chikamatsu, Kazuaki, 2020, CANCER IMMUNOLOGY RESEARCH, 8, 4, 118, 118
Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma, Tada, Hiroe;Takahashi, Hideyuki;Ida, Shota;Nagata, Yurino;Chikamatsu, Kazuaki, 2020, ANTICANCER RESEARCH, 40, 6, 3559, 3564
A Case Report of Acute Angioedema that Showed Dramatic Response to Administration of a C1-inactivator, Tada Hiroe;Matsuyama Toshiyuki;Kudo Takeshi;Chikamatsu Kazuaki, 2017, Nippon Jibiinkoka Gakkai Kaiho, 120, 3, 217, 223
A New Blood Test for Head and Neck Cancers: Liquid Biopsy, Chikamatsu Kazuaki;Tada Hiroe, 2019, Practica Oto-Rhino-Laryngologica, 112, 7, 415, 421
How to use NSAIDs for patients with nasal polyps, Matsuyama Toshiyuki;Tada Hiroe;Chikamatsu Kazuaki, 2019, Journal of Japan Society of Immunology & Allergology in Otolaryngology, 37, 3, 229, 232
Effect of Treatment with Dupilumab for Eosinophilic Chronic Rhinosinusitis, Matsuyama Toshiyuki;Takahashi Hideyuki;Tada Hiroe;Nagata Yurino;Chikamatsu Kazuaki, Jun. 2021, Nippon Jibiinkoka Gakkai Kaiho, 124, 6, 884, 889
当科における上咽頭癌交替療法施行症例についての検討, ;;;;, Apr. 2016, 119, 4, 656
耳下腺筋上皮腫の一例, ;, Aug. 2018, 31, 3, 384
【救急・当直マニュアル-いざというときの対応法】救急外来・当直での処置と治療 感染症・炎症・浮腫 遺伝性血管性浮腫, ;, Apr. 2019, 91, 5, 220
頭頸部扁平上皮癌の循環癌細胞における免疫抑制機構の検討, ;;;;;, Apr. 2019, 122, 4, 662
進行頭頸部扁平上皮癌患者における循環癌細胞の同定とその分子生物学的解析, ;;;;;, Apr. 2019, 122, 4, 662
頭頸部がんの新しい検査 リキッドバイオプシー, ;, Jul. 2019, 112, 7, 415
頭頸部扁平上皮癌におけるPD-L1の発現 腫瘍組織と循環癌細胞の比較, ;;;;, Jun. 2019, 37, 2, 118
重症気管支喘息に合併する好酸球性副鼻腔炎に対してbenralizumabが著効した1例, ;;, Jun. 2019, 37, 2, 136
鼻茸患者に対するNSAIDsの取り扱い方, ;;, Sep. 2019, 37, 3, 229
上咽頭に発生したMelanotic oncocytic metaplasiaの一例, ;;, Aug. 2019, 32, 3, 226
蝶形骨洞腫瘍の鑑別におけるFDG-PET検査の有用性, ;;;, Sep. 2019, 58, 3, 513
進行頭頸部扁平上皮癌患者における循環癌細胞の同定とその臨床的意義について(Clinical implications of circulating tumor cells in advanced head and neck squamous cell carcinoma), ;;, Sep. 2019, 78回, P
マムシグサ誤食による急性喉頭浮腫の1例, ;;;;;;;;;;;;;, Feb. 2020, 124, 2, 369
舌に発生した顆粒細胞腫の一例, ;;;, Aug. 2020, 33, 3, 207
口腔がん微小環境の免疫代謝におけるPD-L1発現の意義, ;;;;, Sep. 2020, 123, 4, 1046
頭頸部癌に対するニボルマブ治療における循環癌細胞の分子生物学的解析, ;;, Oct. 2020, 79回, PE14
末梢血循環癌細胞における遺伝子発現とニボルマブの治療効果の検討, ;;;;;;;;, Apr. 2021, 124, 4, 586
TCGAデータベースを用いた頭頸部癌における解糖系遺伝子発現の網羅的解析, ;;;;;, Apr. 2021, 124, 4, 594
好酸球性副鼻腔炎診療における現在の問題点の検討, ;;;;;;;, Apr. 2021, 124, 4, 600
頭頸部扁平上皮癌患者における循環癌細胞の同定とその臨床意義, ;;;, Dec. 2020, 38, 4, 132
抗IL-5製剤投与後の好酸球性副鼻腔炎患者の鼻茸中好酸球数の評価, ;;;, Dec. 2020, 38, 4, 152
好酸球性副鼻腔炎に対するdupilumabの臨床効果, ;;;;, Jun. 2021, 124, 6, 884
HPV関連がん微小免疫環境における浸潤免疫細胞についての網羅的解析, ;, Aug. 2021, 34, 3, 275
ニボルマブ治療における末梢血循環癌細胞のバイオマーカーとしての意義についての検討, ;;;, May 2021, 1回, 130
Dupilumab投与前後の鼻副鼻腔臨床所見と末梢血中好酸球の変動についての検討, ;;;, May 2021, 1回, 162
頭頸部癌患者に対するニボルマブ治療における末梢血Tリンパ球の動態変化と臨床効果についての検討, ;;, Sep. 2021, 80回, [P14
Prognostic significance and population dynamics of peripheral monocytes in patients with oropharyngeal squamous cell carcinoma., Takahashi Hideyuki;Sakakura Koichi;Tada Hiroe;Kaira Kyoichi;Oyama Tetsunari;Chikamatsu Kazuaki, 12 Jan. 2019, Head & neck, 41, 6
Expression of immune-regulatory molecules in circulating tumor cells derived from patients with head and neck squamous cell carcinoma., Chikamatsu Kazuaki;Tada Hiroe;Takahashi Hideyuki;Kuwabara-Yokobori Yuki;Ishii Hiroki;Ida Shota;Shino Masato, 17 Dec. 2018, Oral oncology, 89
Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma., Takahashi Hideyuki;Sakakura Koichi;Arisaka Yukiko;Tokue Azusa;Kaira Kyoichi;Tada Hiroe;Higuchi Tetsuya;Okamoto Ayako;Tsushima Yoshito;Chikamatsu Kazuaki, Anticancer research, 39, 6
Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma., Tada Hiroe;Takahashi Hideyuki;Kuwabara-Yokobori Yuki;Shino Masato;Chikamatsu Kazuaki, 07 Feb. 2020, Oral oncology, 102
Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma., Tada Hiroe;Takahashi Hideyuki;Ida Shota;Nagata Yurino;Chikamatsu Kazuaki, Anticancer research, 40, 6
舌に発生した顆粒細胞腫の一例, ;;;, Aug. 2020, 33, 3, 207
Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma, Tada, Hiroe;Takahashi, Hideyuki;Kawabata-Iwakawa, Reika;Nagata, Yurino;Uchida, Miho;Shino, Masato;Ida, Shota;Mito, Ikko;Matsuyama, Toshiyuki;Chikamatsu, Kazuaki, 2020, SCIENTIFIC REPORTS, 10, 1
Molecular analysis of circulating tumor cells in patients with head and neck cancer treated with nivolumab, Tada, Hiroe;Takahashi, Hideyuki;Chikamatsu, Kazuaki, 2021, CANCER SCIENCE, 112, 776, 776
The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma, Tada, Hiroe;Takahashi, Hideyuki;Ida, Shota;Mito, Ikko;Matsuyama, Toshiyuki;Chikamatsu, Kazuaki, 2021, ANTICANCER RESEARCH, 41, 2, 885, 893
In vitro assessment of antitumor immune responses using tumor antigen proteins produced by transgenic silkworms, Yamada, Kanae;Masuda, Kei;Ida, Shota;Tada, Hiroe;Bando, Minori;Abe, Kanako;Tatematsu, Ken-ichiro;Sezutsu, Hideki;Oyama, Tetsunari;Chikamatsu, Kazuaki;Takeda, Shigeki, 2021, JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 32, 6
Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma, Mito, Ikko;Takahashi, Hideyuki;Kawabata-Iwakawa, Reika;Ida, Shota;Tada, Hiroe;Chikamatsu, Kazuaki, 2021, SCIENTIFIC REPORTS, 11, 1
Dynamic alterations of circulating T lymphocytes and the clinical response in patients with head and neck squamous cell carcinoma treated with nivolumab, Tada, Hiroe;Takahashi, Hideyuki;Yamada, Kanae;Masuda, Kei;Nagata, Yurino;Uchida, Miho;Shino, Masato;Ida, Shota;Mito, Ikko;Matsuyama, Toshiyuki;Oyama, Tetsunari;Tatematsu, Ken-Ichiro;Sezutsu, Hideki;Takeda, Shigeki;Chikamatsu, Kazuaki, 2022, CANCER IMMUNOLOGY IMMUNOTHERAPY, 71, 4, 851, 863
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma, Takahashi, Hideyuki;Kawabata-Iwakawa, Reika;Ida, Shota;Mito, Ikko;Tada, Hiroe;Chikamatsu, Kazuaki, 2021, SCIENTIFIC REPORTS, 11, 1
Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma, Ida, Shota;Takahashi, Hideyuki;Kawabata-Iwakawa, Reika;Mito, Ikko;Tada, Hiroe;Chikamatsu, Kazuaki, 2021, ORAL ONCOLOGY, 122
Circulating naive and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma, Takahashi, Hideyuki;Sakakura, Koichi;Ida, Shota;Kawabata-Iwakawa, Reika;Matsuyama, Toshiyuki;Tada, Hiroe;Mito, Ikko;Chikamatsu, Kazuaki, 2022, CANCER SCIENCE, 113, 1, 53, 64
Dynamic changes in peripheral T cells and the clinical response in head and neck cancer patients treated with nivolumab, Tada, Hiroe;Takahashi, Hideyuki;Chikamatsu, Kazuaki, 2022, CANCER SCIENCE, 113, 1744, 1744
Circulating T Cell Subsets and ILC2s are Altered in Patients With Chronic Rhinosinusitis With Nasal Polyps After Dupilumab Treatment, Matsuyama, Toshiyuki;Takahashi, Hideyuki;Tada, Hiroe;Chikamatsu, Kazuaki, 2022, AMERICAN JOURNAL OF RHINOLOGY & ALLERGY
Nivolumab投与による抗腫瘍免疫応答の誘導と治療耐性についての検討, ;;;;;;;, Apr. 2022, 125, 4, 758
ニボルマブ治療における頭頸部扁平上皮癌患者の末梢血Tリンパ球の動態と予後についての検討, ;;;;, Mar. 2022, 2回, 87
dupilumab治療における末梢血リンパ球の網羅的プロファイリングと新規バイオマーカーの開発, ;;;;, Mar. 2022, 2回, 140
頭頸部扁平上皮癌におけるtissue resident memory T cellについての検討, ;;;;, Mar. 2022, 2回, 183
癌微小環境におけるエクソソームの働き, ;;;;, Mar. 2022, 2回, 208
Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma., Tada Hiroe;Takahashi Hideyuki;Kawabata-Iwakawa Reika;Nagata Yurino;Uchida Miho;Shino Masato;Ida Shota;Mito Ikko;Matsuyama Toshiyuki;Chikamatsu Kazuaki, 09 Dec. 2020, Scientific reports, 10, 1
The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma., Tada Hiroe;Takahashi Hideyuki;Ida Shota;Mito Ikko;Matsuyama Toshiyuki;Chikamatsu Kazuaki, Anticancer research, 41, 2
In vitro assessment of antitumor immune responses using tumor antigen proteins produced by transgenic silkworms., Yamada Kanae;Masuda Kei;Ida Shota;Tada Hiroe;Bando Minori;Abe Kanako;Tatematsu Ken-Ichiro;Sezutsu Hideki;Oyama Tetsunari;Chikamatsu Kazuaki;Takeda Shigeki, 17 May 2021, Journal of materials science. Materials in medicine, 32, 6
Systemic immune responses are associated with molecular characteristics of circulating tumor cells in head and neck squamous cell carcinoma., Tada Hiroe;Nagata Yurino;Takahashi Hideyuki;Matsuyama Toshiyuki;Ida Shota;Mito Ikko;Chikamatsu Kazuaki, 26 May 2021, Molecular and clinical oncology, 15, 1
Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma., Mito Ikko;Takahashi Hideyuki;Kawabata-Iwakawa Reika;Ida Shota;Tada Hiroe;Chikamatsu Kazuaki, 09 Aug. 2021, Scientific reports, 11, 1
Dynamic alterations of circulating T lymphocytes and the clinical response in patients with head and neck squamous cell carcinoma treated with nivolumab., Tada Hiroe;Takahashi Hideyuki;Yamada Kanae;Masuda Kei;Nagata Yurino;Uchida Miho;Shino Masato;Ida Shota;Mito Ikko;Matsuyama Toshiyuki;Oyama Tetsunari;Tatematsu Ken-Ichiro;Sezutsu Hideki;Takeda Shigeki;Chikamatsu Kazuaki, 31 Aug. 2021, Cancer immunology, immunotherapy : CII, 71, 4
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma., Takahashi Hideyuki;Kawabata-Iwakawa Reika;Ida Shota;Mito Ikko;Tada Hiroe;Chikamatsu Kazuaki, 07 Sep. 2021, Scientific reports, 11, 1
Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma., Ida Shota;Takahashi Hideyuki;Kawabata-Iwakawa Reika;Mito Ikko;Tada Hiroe;Chikamatsu Kazuaki, 08 Sep. 2021, Oral oncology, 122
Circulating naïve and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma., Takahashi Hideyuki;Sakakura Koichi;Ida Shota;Kawabata-Iwakawa Reika;Matsuyama Toshiyuki;Tada Hiroe;Mito Ikko;Chikamatsu Kazuaki, 16 Nov. 2021, Cancer science, 113, 1
Nivolumab投与による抗腫瘍免疫応答の誘導と治療耐性についての検討, ;;;;;;;, Apr. 2022, 125, 4, 758
頭頸部癌基礎研究の深化-若手研究者からの発信- 頭頸部癌における末梢血循環癌細胞の分子生物学的解析, 多田 紘恵, May 2022, 48, 2, 90
ニボルマブ治療における頭頸部扁平上皮癌患者の末梢血Tリンパ球の動態と予後についての検討, ;;;;, Mar. 2022, 2回, 87
dupilumab治療における末梢血リンパ球の網羅的プロファイリングと新規バイオマーカーの開発, ;;;;, Mar. 2022, 2回, 140
頭頸部扁平上皮癌におけるtissue resident memory T cellについての検討, ;;;;, Mar. 2022, 2回, 183
癌微小環境におけるエクソソームの働き, ;;;;, Mar. 2022, 2回, 208
HPV陽性中咽頭癌患者におけるsystemic tumor antigen-specific T cell responseの検討, ;;, Aug. 2022, 35, 3, 274